Financial Partners Capital Management LLC Lowers Holdings in Zoetis Inc. (ZTS)

Financial Partners Capital Management LLC trimmed its stake in Zoetis Inc. (NYSE:ZTS) by 0.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 156,484 shares of the company’s stock after selling 1,048 shares during the period. Zoetis comprises 2.0% of Financial Partners Capital Management LLC’s holdings, making the stock its 15th biggest holding. Financial Partners Capital Management LLC’s holdings in Zoetis were worth $9,761,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently added to or reduced their stakes in ZTS. Northwestern Mutual Wealth Management Co. lifted its position in shares of Zoetis by 16.8% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock worth $100,000 after purchasing an additional 230 shares during the period. Guardian Life Insurance Co. of America lifted its position in shares of Zoetis by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,905 shares of the company’s stock worth $102,000 after purchasing an additional 13 shares during the period. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Zoetis in the 1st quarter worth approximately $111,000. Harfst & Associates Inc. lifted its position in shares of Zoetis by 16.1% in the 2nd quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock worth $117,000 after purchasing an additional 260 shares during the period. Finally, Almanack Investment Partners LLC. purchased a new stake in shares of Zoetis in the 2nd quarter worth approximately $119,000. 93.20% of the stock is owned by institutional investors.

WARNING: “Financial Partners Capital Management LLC Lowers Holdings in Zoetis Inc. (ZTS)” was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2017/10/10/financial-partners-capital-management-llc-lowers-holdings-in-zoetis-inc-zts.html.

Several brokerages have recently weighed in on ZTS. BidaskClub raised shares of Zoetis from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 12th. Cowen and Company set a $70.00 price target on shares of Zoetis and gave the stock a “buy” rating in a research report on Monday, July 17th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $75.00 price target on shares of Zoetis in a research report on Tuesday, September 26th. Deutsche Bank AG reaffirmed a “buy” rating and issued a $65.00 price target (up previously from $62.00) on shares of Zoetis in a research report on Monday, July 17th. Finally, Hilliard Lyons began coverage on shares of Zoetis in a research report on Tuesday, June 20th. They issued a “buy” rating and a $77.00 price target for the company. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have assigned a buy rating to the stock. Zoetis currently has an average rating of “Buy” and an average target price of $65.44.

Shares of Zoetis Inc. (NYSE ZTS) traded up 0.06% on Tuesday, reaching $63.77. 651,610 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $63.50 and a 200 day moving average of $60.66. Zoetis Inc. has a one year low of $46.86 and a one year high of $65.83. The firm has a market capitalization of $31.19 billion, a P/E ratio of 36.05 and a beta of 1.02.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.53 earnings per share for the quarter, hitting the consensus estimate of $0.53. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. Zoetis had a net margin of 17.50% and a return on equity of 62.49%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.49 EPS. On average, equities research analysts predict that Zoetis Inc. will post $2.34 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be given a dividend of $0.105 per share. The ex-dividend date is Wednesday, November 8th. This represents a $0.42 annualized dividend and a dividend yield of 0.66%. Zoetis’s dividend payout ratio is presently 23.73%.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

What are top analysts saying about Zoetis Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zoetis Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit